Stryker CEO Lobo: “For every POD that goes away a new POD seems to pop up” (Stryker Earnings Conference Call)
Operator: Welcome to Stryker’s First Quarter 2014 Earnings Conference Call. My name is Eric and I’ll be your operator for today’s call. At this time all participants are in a listen-only mode. Following the conference we will conduct a question-and-answer session. This conference call is being recorded for replay purposes.
Before we begin, I would like to remind you that the discussions during this conference call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company’s most recent filings with the SEC. Also, discussions will include certain non-GAAP financial measures. Reconciliation to the most directly comparable GAAP financial measures can be found in today’s press release that is an exhibit to Stryker’s current report on Form 8-K filed today with the SEC.
Endoscopy had another solid quarter. Medical was steady while Sustainability Solutions was slowed by some product lifecycle challenges. U.S. Neurotechnology had another stellar quarter with 11% growth as all three businesses, neurovascular, ne...
